News Release
Investors
Partners
Our Pipeline

We are building a pipeline of compelling investigational therapies targeting indications for which we believe gene therapy can have the greatest impact in patients with rare genetic diseases.

Our Products

Hunterase®, (iduronidase-2-sulfatase) is a recombinant human Enzyme Replacement Therapy (ERT).

Corporate Culture & Career

To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China

Contact Us
Beijing
Beijing
Suite 301,3F,Timeloit, No. 17 RongChuang Road, Chaoyang District, Beijing, China
Tel: 010 84148018
Fax: 010 84148017
Adverse Events Reporting: PV@canbridgepharma.com
Shanghai
Shanghai
Suite 708, Huawen International Mansion, No.999, West Zhongshan Road, Changning District, Shanghai
Tel: 021 52956319
Fax: 021 52665300
Adverse Events Reporting: PV@canbridgepharma.com
Hong Kong
Hong Kong
Unit A131, 16/F, Sun Life Tower, The Gateway, Harbour City, 15 Canton Road, Tsim Sha Tsui
Taiwan
Taiwan
Room B06, 11F, No.281, Sec. 4, Xinyi Road, Da'an District, Taipei, 10681, Taiwan
Burlington
Burlington
4 Burlington Woods Drive, Burlington, MA 01803, USA